1. Home
  2. ENOV vs CLM Comparison

ENOV vs CLM Comparison

Compare ENOV & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • CLM
  • Stock Information
  • Founded
  • ENOV 1995
  • CLM 1987
  • Country
  • ENOV United States
  • CLM United States
  • Employees
  • ENOV N/A
  • CLM N/A
  • Industry
  • ENOV Fluid Controls
  • CLM Finance/Investors Services
  • Sector
  • ENOV Industrials
  • CLM Finance
  • Exchange
  • ENOV Nasdaq
  • CLM Nasdaq
  • Market Cap
  • ENOV 1.7B
  • CLM 2.0B
  • IPO Year
  • ENOV 2008
  • CLM N/A
  • Fundamental
  • Price
  • ENOV $33.65
  • CLM $8.23
  • Analyst Decision
  • ENOV Strong Buy
  • CLM
  • Analyst Count
  • ENOV 5
  • CLM 0
  • Target Price
  • ENOV $58.00
  • CLM N/A
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • CLM 1.4M
  • Earning Date
  • ENOV 08-06-2025
  • CLM 01-01-0001
  • Dividend Yield
  • ENOV N/A
  • CLM 18.74%
  • EPS Growth
  • ENOV N/A
  • CLM N/A
  • EPS
  • ENOV N/A
  • CLM N/A
  • Revenue
  • ENOV $2,150,191,000.00
  • CLM N/A
  • Revenue This Year
  • ENOV $8.23
  • CLM N/A
  • Revenue Next Year
  • ENOV $6.18
  • CLM N/A
  • P/E Ratio
  • ENOV N/A
  • CLM N/A
  • Revenue Growth
  • ENOV 18.32
  • CLM N/A
  • 52 Week Low
  • ENOV $28.83
  • CLM $6.25
  • 52 Week High
  • ENOV $49.83
  • CLM $8.84
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 56.27
  • CLM 73.29
  • Support Level
  • ENOV $30.84
  • CLM $8.08
  • Resistance Level
  • ENOV $33.95
  • CLM $8.19
  • Average True Range (ATR)
  • ENOV 1.15
  • CLM 0.09
  • MACD
  • ENOV 0.33
  • CLM 0.01
  • Stochastic Oscillator
  • ENOV 90.53
  • CLM 100.00

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.

Share on Social Networks: